Cannabis Bioscience International Holdings, Inc. (CBIH) Return on Capital Employed (2024 - 2026)

Cannabis Bioscience International Holdings has reported Return on Capital Employed for 3 years, with the latest figure at 33.03% in Q1 2026.

• Quarterly Return on Capital Employed fell 41.0% year-over-year to 33.03% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 33.03% (down 41.0% YoY) and the FY2025 annual result came in at 46.74%, down 1171.0% from the prior year.
• Return on Capital Employed declined to 33.03% in Q1 2026 per CBIH's latest filing, from 38.98% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 100.43% in Q1 2024 and troughed at 33.03% in Q1 2026.
• A 3-year average of 48.7% and a median of 41.68% in 2024 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2025 and 2026: Return on Capital Employed plunged 6699 bps in 2025, then plunged 41 bps in 2026.
• Over 3 years, Return on Capital Employed stood at 41.68% in 2024, then decreased by 6 bps to 38.98% in 2025, then retreated by 15 bps to 33.03% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 33.03%, 38.98%, and 40.25% for Q1 2026, Q4 2025, and Q3 2025 respectively.